Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas

Authors

  • Andrew Kaz,

    1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
    2. Department of Medicine, University of Washington Medical School, Seattle, WA
    Search for more papers by this author
  • Young-Ho Kim,

    1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
    2. Department of Medicine, Samsung Medical Center, Seoul, Korea
    3. Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
    Search for more papers by this author
  • Slavomir Dzieciatkowski,

    1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
    Search for more papers by this author
  • Henry Lynch,

    1. Department of Preventive Medicine, Creighton University Medical School, Omaha, NB
    Search for more papers by this author
  • Patrice Watson,

    1. Department of Preventive Medicine, Creighton University Medical School, Omaha, NB
    Search for more papers by this author
  • Mary Kay Washington,

    1. Department of Pathology, Vanderbilt University Medical School, Nashville, TN
    Search for more papers by this author
  • Li Lin,

    1. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
    Search for more papers by this author
  • William M. Grady

    Corresponding author
    1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
    2. Department of Medicine, University of Washington Medical School, Seattle, WA
    3. R&D Service, VA Puget Sound Healthcare System, Seattle, WA
    • Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., D4-100, Seattle, WA 98109, USA
    Search for more papers by this author
    • Fax: +1206-667-2917.


Abstract

Colorectal cancer (CRC) forms through a series of histologic steps that are accompanied by mutations and epigenetic alterations, which is called the polyp-cancer sequence. The role of epigenetic alterations, such as aberrant DNA methylation, in the polyp-cancer sequence in sporadic CRC and particularly in hereditary colon cancer is not well understood. Consequently, we assessed the methylation status of CDKN2A/p16, MGMT, MLH1 and p14ARF in adenomas arising in the Lynch syndrome, a familial colon cancer syndrome caused by MLH1 and MSH2 mutations, to determine if DNA methylation is a “second hit” mechanism in CRC and to characterize the role of DNA methylation in the polyp phase of the Lynch syndrome. We found MLH1 and p14ARF are methylated in 53 and 60% of the Lynch syndrome adenomas and in 4 and 20% of sporadic adenomas, whereas CDKN2A/p16 and MGMT are methylated in 6 and 14% of the Lynch syndrome adenomas versus 50 and 64% of sporadic adenomas. Therefore, the frequency and pattern of gene methylation varies between the Lynch syndrome and sporadic colon adenomas, implying differences in the molecular pathogenesis of the tumors. MLH1 methylation in the Lynch syndrome adenomas suggests gene methylation might have a role in the initiation of these neoplasms. © 2007 Wiley-Liss, Inc.

Ancillary